The analysis uncovers how ACC1 influences glioma cell behavior by suppressing SDH activity, indicating therapeutic relevance.
Key Points
ACC1 knockdown increases migration and invasion of U251 glioma cells, promoting a tumorigenic phenotype.
The study shows that ACC1 overexpression inhibits proliferation and migration in glioma cell lines, highlighting its tumor suppressor role.
Mechanistically, reduced ACC1 levels lead to Epigenetic suppression of SDH through P300 and increased DNMT1 levels enhancing ROS production.
Analysis of clinical data reveals that low ACC1 expression correlates with poor survival outcomes in patients with glioma, suggesting its prognostic value.